Brazil has approved Embrapa — the country’s premier agricultural research agency — to conduct long-term cannabis research, develop a national seed bank, and engineer industrial hemp varieties. The move positions Brazil as an emerging player in global cannabis science and future hemp export markets.

Rep. Dina Titus is demanding answers from the U.S. Attorney General after a DOJ memo signaled renewed enforcement on cannabis offenses. Her letter raises major concerns for state-legal operators who need clear federal guidance to protect their businesses and plan for the future.

A new federal amendment will ban hemp-derived THC products exceeding 0.4 mg THC per container, effectively eliminating the intoxicating hemp category. The rule will reshape the $28 billion hemp-THC industry and force businesses to prepare for major operational changes.

A federal funding bill signed by President Donald Trump includes language banning most hemp-derived THC beverages after November 2026. The move threatens the booming “cannabis drink” category and forces beverage companies to prepare now for reformulation, pivoting, or shutdown.

The New York Medical Cannabis Industry Association has filed a lawsuit against state regulators, claiming mismanagement allowed illicit cannabis to overrun the market. The case could force major changes in enforcement and reshape the state’s cannabis industry.

The Trump administration declined to file a government brief in a major Supreme Court cannabis case, signaling reduced federal engagement in shaping cannabis policy. The move highlights ongoing uncertainty at the federal level as courts, states, and agencies continue defining the future of cannabis regulation.

Rep. Nancy Mace has introduced draft legislation aimed at reversing the new federal ban on intoxicating hemp products. The proposal could offer major relief to the $28 billion hemp-THC sector, which was blindsided by the ban buried in the government-funding deal.

New York’s average cannabis price dropped from $38.61 to $32.15 as licensed store openings and expanded product selection increased competition. This decline shows the market is maturing — but it also raises new challenges for operators navigating shrinking margins and rising compliance pressure.

The new government-funding deal includes a provision limiting hemp-derived THC beverages to just 0.4 mg of THC per serving — effectively dismantling the booming low-dose beverage category. Companies that scaled in this space now face reformulation, revenue loss, and major regulatory challenges.

Texas avoided a state-level THC ban, but a new federal spending bill could outlaw most hemp-derived THC products nationwide. Industry leaders warn the move could devastate the multi-billion-dollar hemp sector and force thousands of operators to pivot or shut down.

A new federal spending bill includes language banning many synthetic cannabinoids, closing a loophole in the 2018 Farm Bill that enabled a booming intoxicating-hemp market. The move marks a major federal shift and will reshape hemp-THC businesses nationwide.

A new multi-state study found rising cases of occupational asthma — and some fatalities — among cannabis cultivation, trimming, and packaging workers. The research highlights urgent gaps in workplace safety as the cannabis industry scales and underscores the need for stronger compliance and protection.

At the ICIA Summit, tribal leaders warned that federal hemp-THC regulations could heavily disrupt tribal cannabis markets if operators don’t adapt quickly. The message was clear: sovereignty is a strength, but proactive compliance and strategic planning are essential for long-term success.

Congress passed new legislation narrowing the federal definition of hemp, imposing strict THC limits, and banning synthetic cannabinoids. The move could reshape the $28B hemp-THC sector and force major operational changes across manufacturing, retail, and online markets.

A proposed federal spending bill includes language that could ban most ingestible hemp-derived THC products, threatening an estimated $28 billion industry. The measure would eliminate Delta-8, THCA, and other intoxicating hemp items — reshaping the national marketplace overnight.

A woman-led biotech company is developing prescription-grade cannabinoid treatments for women’s health conditions like endometriosis. Their work aims to bring cannabis into mainstream medical and pharmaceutical channels — marking a breakthrough moment for both science and the cannabis industry.

A federal spending bill to reopen the government includes provisions to ban many hemp-derived THC products, such as Delta-8 and hemp-based gummies and beverages. The move could devastate parts of the hemp industry and signals increasing federal intervention in cannabis regulation.

The U.S. Hemp Roundtable warns that new Senate language could “wipe out” 95% of the hemp industry, eliminating thousands of jobs and billions in revenue. The group is urging Congress to remove the proposal from the federal spending bill and pursue balanced hemp regulation instead.

A new Oregon study finds that adults living near licensed cannabis stores report less heavy drinking and more marijuana use, especially among Gen Z and Baby Boomers. The findings suggest cannabis access may be replacing alcohol as a preferred wellness or social alternative.

Congress’s latest budget deal would restrict hemp-derived THC products while removing provisions allowing VA doctors to recommend medical marijuana. The move tightens federal hemp oversight and highlights how cannabis reform momentum is slowing at the national level.